Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02451618 · ClinicalTrials.gov registry record
Novel Epidermal Recording and Detection of Seizures
A clinical trial, sponsored by Sharp HealthCare.
- Terminated
- Registry status
- 13
- Enrollment target
NCT02451618: Clinical Trial study, sponsored by Sharp HealthCare.
NCT02451618 is a clinical trial that was terminated before completion, run by Sharp HealthCare. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02451618 was terminated before completion, sponsored by Sharp HealthCare.
- TERMINATED
- Registry status
- 13 participants
- Enrollment target
Study Summary
For any newborn that exhibits possible seizure activity or has altered mental status of unknown etiology, continuous bedside EEG recording is the standard of care to detect subclinical seizure activity. The experimental aspect of this study will be the application of test electrodes (EES or EKG) to evaluate if the electrodes can be used to produce a continuous bedside recording of brain activity in the same manner as an EEG recording, while ideally producing less irritation of newborn skin than conventional EEG electrodes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2015-01-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02451618
The ClinicalTrials.gov registry entry for NCT02451618 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sharp HealthCare, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02451618 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02451618 about?
NCT02451618 is a clinical study titled "Novel Epidermal Recording and Detection of Seizures". For any newborn that exhibits possible seizure activity or has altered mental status of unknown etiology, continuous bedside EEG recording is the standard of care to detect subclinical seizure activity. The experimental aspect of this study will be the application of test electrodes (EES or EKG) to ...
What is the current status of trial NCT02451618?
This trial is currently terminated. The enrollment target is 13 participants. The study started on 2015-01-27.
Who is sponsoring clinical trial NCT02451618?
This trial is sponsored by Sharp HealthCare, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.